Recently, Yichang Renfu Pharmaceutical's subsidiary, Yichang Renfu TeYi Food Co., Ltd., received the "Registration Certificate for Special Medical Purpose Formula Foods" issued by the State Administration for Market Regulation. The company's developed special medical purpose liquid formula food, "TeYiBei," has been approved for market launch (registration number: Guoshi Zhu Zi TY20250018). This is the first liquid formula food approved in Hubei Province.

Established in November 2017, Yichang Renfu TeYi Company is a high-tech enterprise integrating the research, production, and sales of special medical foods. It is also the first enterprise in Hubei Province to obtain registration certificates and production licenses for special medical purpose formula foods. The company is committed to developing special medical purpose formula foods that meet the nutritional needs of people with limited food intake, digestive and absorption disorders, metabolic disorders, or specific disease states. Previously, it has launched two special medical purpose electrolyte formula foods, "ShuNeng" and "TeYiXin," and one special medical purpose protein component formula food, "TeYiShu."

According to statistics, the number of surgical procedures for inpatients in China in 2023 was approximately 96 million. According to the "Guidelines for Nutritional Support in the Perioperative Period for Adults," the prevalence of malnutrition in surgical patients is 20%-80%. The approved "TeYiBei" special medical purpose liquid formula food provides a new clinical nutritional support solution for surgical and critically ill patients.

"TeYiBei" is a special medical purpose liquid formula food mainly used for people who need to restrict fat intake or have digestive and absorption disorders, such as nutritional support for early postoperative patients and nutritional support for patients with acute pancreatitis. This product is fat-free, with energy provided by hydrolyzed whey protein and carbohydrates. It also contains various vitamins and minerals to reduce the digestive burden on the patient's gastrointestinal system, providing rich and precise nutritional support.

This approval marks another breakthrough for Yichang Renfu Pharmaceutical in the field of special medical purpose formula foods. In the future, the company will continue to research and develop high-quality special medical products focusing on the perioperative period and tumor critical illness areas to better meet patient needs.